Cytotoxic T lymphocyte-associated antigen 4 inhibition increases the antitumor activity of adoptive T-cell therapy when carried out with naïve rather than differentiated T cells

TAKESHI ISHIKAWA, SATOKO ADACHI, TETSUYA OKAYAMA, SATOSHI KOKURA, KATSURA MIZUSHIMA, TOSHIFUMI DOI, TATSUZO MATSUYAMA, NAOYUKI SAKAMOTO, KAZUHIRO KATADA, KAZUHIRO KAMADA, KAZUHIKO UCHIYAMA, OSAMU HANDA (+4 others)
2015 Oncology Reports  
Although treatment with an antibody against cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) combined with multiple therapeutic interventions has been explored, the effect of combination therapy with CTLA-4 inhibition and adoptive T-cell therapy has not been determined. In the present study, our aim was to determine whether CTLA-4 inhibition, combined with adoptive transfer of T cells at different stages of differentiation, exhibits synergistic antitumor effects in a murine colon cancer
more » ... l. Mice bearing subcutaneous tumors were administered adoptive T-cell transfer of CD62L high or CD62L low cells combined with an anti-CTLA-4 antibody (α-CTLA-4) or control immunoglobulin G. Subcutaneous tumors were harvested, and the antitumor effects and helper T-cell polarization were analyzed. CTLA-4 inhibition combined with CD62L high cell administration showed the strongest antitumor effect. Combination therapy increased the number of CD3 + cells within the tumor. Moreover, CTLA-4 inhibition induced polarization of T cells infiltrating the tumor toward the T helper 1 lineage, and suppressed the frequency of regulatory T cells within the tumor, particularly in combination with CD62L high T-cell transfer. This is the first report demonstrating that the efficacy of α-CTLA-4 and adoptive T-cell transfer combination therapy depends on the state of differentiation of the transferred T cells. Our data support the notion that a combination of α-CTLA-4 and adoptive T-cell transfer containing an abundance of naïve phenotype cells could potentially exert antitumor effects in a clinical setting.
doi:10.3892/or.2015.3815 pmid:25738564 fatcat:xmjykksntnfdbnfyngrvqc57ey